Having previously determined the complete amino acid sequence of 2-keto-4-hydroxyglutarate aldolase from Escherichia coli (C. J. Vlahos and E. E. Dekker, J. Biol. Chem. 263:11683-11691, 1988), we amplified the gene that codes for this enzyme by the polymerase chain reaction using synthetic degenerate deoxyoligonucleotide primers. The amplified DNA was sequenced by subcloning the polymerase chain reaction products into bacteriophage M13; the nucleotide sequence of the gene was found to be in exact agreement with the amino acid sequence of the gene product. Overexpression of the gene was accomplished by cloning it into the pKK223.3 expression vector so that it was under control of the tac promoter and then using the resultant plasmid, pDP6, to transform E. coli DHSatF'IQ. When this strain was grown in the presence of isopropyl P-D-thiogalactopyranoside, aldolase specific activity in crude extracts was 80-fold higher than that in wild-type cells and the enzyme constituted approximately 30% of the total cellular protein. All properties of the purified, cloned gene product, including cross-reactivity with antibodies elicited against the wild-type enzyme, were identical with the aldolase previously isolated and characterized. A strain of E. coli in which this gene is inactivated was prepared for the first time by insertion of the kanamycin resistance gene cartridge into the aldolase chromosomal gene.
2-Keto-4-hydroxyglutarate (KHG) aldolase (4-hydroxy-2-oxoglutarate glyoxylate-lyase [EC 4.1.3.16; 4-hydroxy-2-oxoglutarate = pyruvate + glyoxylate]) of Escherichia coli is a novel trimeric enzyme (30) . Past enzymological and radiotracer studies (7) led to the suggestion that KHG aldolase participates in regulation of the intracellular level of glyoxylate in E. coli (and possibly other prokaryotic) cells; in mammals, it is well established that it catalyzes a central reaction in hydroxyproline catabolism (19) . This enzyme has been obtained in homogeneous form from extracts of E. coli (5) , as well as bovine liver (3) and kidney (12) . KHG aldolases from E. coli and bovine liver and kidney differ in size (Mrs, 66,000, 120,000, and 140,000, respectively), and whereas the liver and kidney enzymes are homotetramers, that from E. coli has a trimeric subunit structure. Another difference is that the liver and kidney enzymes are virtually nonstereospecific in cleaving or forming both optical isomers of KHG (13) ; the E. coli enzyme, in contrast, is stereoselective for L-KHG. Mechanistically, KHG aldolase from all sources so far examined is a class I or "lysine-type" aldolase, catalyzing the reaction via a mechanism involving Schiff base formation between KHG or pyruvate and the e-amino group of an active-site lysine residue (14, 20) . Most interestingly, and regardless of the source, KHG aldolase is bifunctional, efficiently catalyzing P-decarboxylation of oxalacetate as well as aldol cleavage or formation of KHG. The P-decarboxylase/aldolase activity ratios, however, are 0.2, 0.5, and 1.0, respectively, for the kidney, liver, and E. coli enzymes. The availability, therefore, of pure KHG aldolase preparations from a prokaryotic source and eukaryotic sources that are similar in some molecular and/or catalytic properties but significantly different in others provides an attractive system for studying enzyme structure-function interrelationships.
First in-depth studies are being carried out with KHG * Corresponding author.
aldolase from E. coli. In previous work, we succeeded in determining the complete amino acid sequence of the protein (27) ; it consists of 213 amino acids with subunit and trimer molecular masses of 22 and 66 kDa, respectively. Selective chemical modification-inactivation studies, followed by peptide isolation and sequencing endeavors, enabled us to determine that glutamate residue 45 (28), arginine residue 49 (27, 29) , and lysine residue 133 (27) are each required for catalytic activity. Such efforts await confirmation and, possibly, new insights by application of molecular biological techniques. This report describes our success in cloning the hga (KHG aldolase) gene that codes for the primary structure of the enzyme and is the first to describe the nucleotide sequence of this gene from any source. In addition, the gene was overexpressed in E. coli, allowing for large quantities of the enzyme to be formed, and the cloned fragment, which included a selectable marker, was used to inactivate the gene on the E. coli chromosome by double recombination. (17) . After electrophoresis, the proteins were electroeluted onto nitrocellulose and the membranes were blocked with 5% powdered milk-1% bovine serum albumin. Subsequent reaction was carried out with crude rabbit antiserum (diluted 1,000-fold in blocking solution) raised against purified E. coli KHG aldolase. Antibodies against the aldolase were elicited by subcutaneously injecting the pure protein into three rabbits (-500 gig for each animal over an interval of about 8 weeks), and antiserum was subsequently prepared and collected as described by Harlow and Lane (9) . Proteins electroeluted onto nitrocellulose were probed with purified goat anti-rabbit immunoglobulin G antibody coupled with 3,000-fold-diluted horseradish peroxidase. The latter was then detected by using the color-developing reagent 4-chloro-1-naphthol (Bio-Rad Laboratories). Controls probed with preimmune serum were negative.
MATERIALS AND METHODS
Preparation and assay of KHG aldolase. KHG aldolase was purified to homogeneity, as described before (5) 
RESULTS
Cloning of the coding region of the hga gene. Two oligodeoxynucleotide primers, corresponding to the known 10 N-terminal and the 10 C-terminal amino acids of E. coli KHG aldolase (27) , were synthesized by using deoxyinosine at the third ambiguous position of selected codons. An EcoRI site was placed at the 5' end of the N-terminal primer, and a seven-base nucleotide sequence, ATTCGAA, containing a stop codon and a HindIII site, was included at the 5' end of the C-terminal primer to facilitate subsequent cloning of PCR products. The by agarose gel electrophoresis showed a single major band of the predicted size (Fig. 1) .
Subcloning of PCR products for sequencing into Ml3mpl8 and M13mpl9. DNA fragments obtained by digestion of the PCR products with EcoRI and HindIII were ligated into M13mpl8 and M13mpl9 replicative forms of DNA, previously cut by EcoRI and HindIII, and then used to transfect E. coli DH5aF'. White recombinants of M13, into which the 640-bp EcoRI-HindlIl fragment had been inserted, were picked from plates containing 5-bromo-4-chloro-3-indolyl-,B-D-galactopyranoside and isopropyl-p-D-thiogalactopyranoside. Single-stranded templates were prepared (23), and DNA sequencing was performed as described in the Stratagene DNA sequencing manual, by using the Klenow fragment of DNA polymerase with [a-35S]dATP and a 17-base universal primer. As sequencing progressed, newly uncovered restriction endonuclease sites were used to clone smaller fragments to obtain the complete gene sequence. The complete nucleotide sequence was assembled from data for overlapping sequences on both strands. The complete nucleotide sequence determined in this manner was derived from both strands; it and the corresponding deduced amino acid sequence of E. coli KHG aldolase are shown in Fig. 2 . The nucleotide sequence determined exactly confirmed the previously reported amino acid sequence of the protein (27) . Nucleotide sequence analysis indicated that this gene displays highly selective codon usage (data not shown). For example, of the six possible leucine codons, only two (UUG and CUG) are used; likewise, the GGU codon is preferentially used for glycine and so also is CCG for proline. Overall, the G+C content is 57% and comparison of the codon usage in this gene with the codon preference statistics of weakly and strongly expressed E. coli genes (6) (Fig. 3) . This hybrid plasmid (designated pDP6) was used to transform E. coli DH5aF'IQ. A stop codon was included immediately after the aldolase C-terminal amino acid (i.e., leucine); the first stop codon encountered in pKK223.3 is 78 bases downstream from the C-terminal amino acid, which would give an expressed gene product having 26 additional amino acids at the C terminus.
Characterization of the hga gene product. Plasmid pDP6 was transformed into wild-type E. coli DH5aF'IQ, and the proteins expressed were analyzed for the presence of the cloned aldolase gene product by SDS-polyacrylamide gel electrophoresis. Crude extracts prepared by sonication of this strain showed a major 22-kDa polypeptide (Fig. 4A,  lanes 2 and 3) , whereas a polypeptide of the corresponding size was barely detectable in extracts of the wild-type organism (Fig. 4A, lane 1) . Under the electrophoretic conditions used, the expressed protein migrated in a manner identical to that of native KHG aldolase purified to homogeneity (Fig. 4A, lane 4) . The higher than that of wild-type cells, and it was calculated that the cloned gene product constituted -30% of the total cellular protein.
Past studies had shown that pure KHG aldolase from extracts from either E. coli (5) or mammalian sources (3, 12) differs in many fundamental respects from other class I (lysine-type) aldolases. Furthermore, although E. coli KHG aldolase has some properties similar to those of the same enzyme from liver or kidney, it is markedly dissimilar in others. A$ a consequence, we purified KHG aldolase to homogeneity from extracts of E. coli(pDP6) by the usual procedure (5) and compared it with the pure enzyme from wild-type E. coli cells. As Table 1 shows, the cloned enzyme has the very same properties. The difference in specific activity is not considered to be significant, since values ranging from the low 40s to the high 50s have routinely been obtained for the pure enzyme from wild-type cells. Subunit structure was established by determining its mass after dissociation and subsequent SDS-gel electrophoresis and also by visualization and mass determination of the species separated on SDS-gels after cross-linking with dimethyl suberimidate. The same cross-reactivity with antibodies raised against the purified wild-type enzyme was also observed (Fig. 4B) . Collectively, these data clearly indicate that the cloned gene product is the same as the aldolase previously isolated and characterized.
Inactivation of the hga gene. We used the method of FIG. 4. Overproduction of the KHG aldolase polypeptide in E. coli harboring plasmid pDP6. (A) SDS-polyacrylamide gel electrophoresis. Lanes: 1, sonicated extracts (50 ,ug) of wild-type E. coli without the plasmid; 2 and 3, sonicated extracts (50 ,ug) of wild-type E. coli carrying plasmid pDP6; 4, purified KHG aldolase (10 ,ug) from wild-type E. coli. (B) Western blot analysis of KHG aldolase, as described in Materials and Methods. Lanes: 1, sonicated extracts of wild-type E. coli without the plasmid; 2 and 3, sonicated extracts of wild-type E. coli carrying plasnlid pDP6; 4, purified KHG aldolase (10 ,ug) from wild-type E. coli.
inserting a selectable marker into the cloned fragment of DNA and then reintroduced it into its original site in the genome by transforming the linear DNA into E. coli JC7623 (16) . JC7623, a recB21 recC22 sbcB15 strain, has been used frequently to transform linear DNA (1, 11, 15, 24, 25) . Successful use of this technique when the amount of homologous DNA used contained 0.3-and 2.4-kilobase regions flanking the insertion has been reported (31) . Plasmid pDP6KS was constructed by ligating the kanamycin resistance gene cartridge (1,252-bp HinclI fragment of plasmid pUC4K) into the single SmaI site (which lies within the hga gene) of plasmid pDP6. After linearization and transformation of plasmid pDP6KS into E. coli JC7623 (as described in Materials and Methods), a new kanamycin-resistant strain, E. coli RE91, with a mutation in the chromosomal hga gene was obtained. Inactivation of the chromosomal gene was confirmed by showing that (i) the strain contained no detectable plasmid DNA; (ii) RE91 grown aerobically for 16 h at 37°C showed no detectable KHG aldolase activity (up to 4 mg of protein was analyzed), whereas good levels of activity (190 Klett units with 0.5 mg of protein) were seen with comparable extracts of strain JC7623; (iii) no inhibitory substance was judged to be present by assaying mixed extracts of strains RE91 and JC7623; and (iv) strain RE91 retained other auxotrophic markers present in parental strain JC7623, as determined by plating on appropriate media. The absence of the aldolase protein and, hence, any activity in strain RE91 was confirmed by Western blotting (Fig. 5A) One g'oal, therefore, is to establish structure-function interrelationships of KHG aldolase from prokaryotic and eukaryotic sources. First efforts have concentrated on the pure enzyme protein from E. ccli; some details of its structure and of amino acid residues that are catalytically essential have been uncovered (26) (27) (28) (29) Efforts to sequence the DNA regions flanking the hga gene are now in progress. When the cloned gene was overexpressed under control of the tac promoter, markedly elevated levels of the gene product were found. Attainment of the goal of purifying large amounts of the homogeneous enzyme for possible crystallization and X-ray crystallographic studies of this trimeric protein now seems possible. Definitive structure-function interrelationships of E. coli KHG aldolase can now also be addressed by site-directed mutagenesis of specific amino acid residues. Furthermore, site-directed insertion of the kanamycin resistance gene into the E. coli chromosomal gene enabled us to isolate a mutant lacking KHG aldolase activity. This mutant strain will be useful in expressing and characterizing mutant forms of the enzyme obtained by site-directed mutagenesis, in cloning the complete gene with its own regulatory sequences, and in mapping its locus on the chromosome.
